Highlights from NFCR’s GSAC24

The NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship, took place on October 18, 2024.

This year’s summit brought together leading cancer scientists, entrepreneurs, investors, business leaders, and advocates, fostering an environment rich in collaboration and innovation.

Participants engaged in discussions on cutting-edge research, breakthrough technologies, and entrepreneurial strategies aimed at transforming cancer treatment and prevention. Keynote speeches from renowned experts highlighted the latest advancements in cancer research, while panel discussions provided insights into the intersection of science and business.

The event also celebrated outstanding contributions to the field with awards recognizing exceptional individuals and organizations dedicated to cancer research and entrepreneurship. The networking opportunities allowed attendees to forge valuable connections, sparking new ideas and partnerships.

As the summit concluded, attendees left inspired and energized, with a shared commitment to continue the fight against cancer. Mark your calendars for next year’s NFCR Global Summit on October 24, 2025, as the community unites once again to drive progress and innovation in cancer research.

Professionals and healthcare organisations shared their insights on social media:

NFCR:

“We have officially kicked-off!”

NFCR:

“To make rapid advances, we need to work together, We need to work together synergistically, Collaboration is key. – Margaret Foti!”

AIM-HI Accelerator Fund:

“Please join us in congratulating the 2024 AIM-HI Women’s Venture Competition Award Winners: Nabanita Nawar, , Co-Founder and CEO, HDAX Therapeutics, and Paraskevi Giannakakou.”

AIM-HI Accelerator Fund:

“Congratulations Margaret Foti! You are truly an inspiration in the cancer research ecosystem.”

NFCR:

“Thank you Lisa Coussens and Kornelia Polyak for attending this year’s Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship!”

AIM-HI Accelerator Fund:

“Thank you to our CEO Sujuan Ba for starting off our third session of the day!”

NFCR:

“Our second panel of the day has just begun! Thank you to Dr. Doti from AstraZeneca for being our emcee for this amazing panel.”

Margaret Foti:

“AACR Past President Lisa Coussens moderated an outstanding session on ‘New Approaches to Cancer Treatments’ during today’s National Foundation for Cancer Research Global Summit and Award Ceremonies.”

NFCR:

“Thank you again to all of our sponsors who made today possible!”

Deborah Moorad:

“Excited for this day. Since 1973, NFCR has made a commitment to make a difference in cancer care and cancer research.”

Rick Buck:

“With colleagues and our ⁦AACR CEO⁩ Dr. Foti being honored today with the AIM-HI Beacon Award for Women Leaders in Oncology NFCR Global Summit and Awards Ceremony in DC.”

AIM-HI Accelerator Fund:

“The innovation shown in Clasp Therapeutics’ presentation during our 3rd session of the day is truly promising! We cannot wait to see how these concepts will change the cancer treatment landscape!”

AIM-HI Accelerator Fund:

“We are so excited to welcome back Degron Therapeutics, last year’s Women’s Venture Competition finalist. The progress that has been made in just the last 12 months is astounding!”

Rick Buck:

“Congratulations to our ⁦AACR CEO Dr. Foti on receiving the Beacon Award for Women Leaders in Oncology this afternoon from AIM-HI Accelerator Fund and NFCR this afternoon.”

For more posts like this, visit oncodaily.com